<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">49253</article-id><article-id pub-id-type="doi">10.7554/eLife.49253</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary Ca<sub>V</sub>β subunits</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-91508"><name><surname>Morgenstern</surname><given-names>Travis</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2634-8470</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146303"><name><surname>Park</surname><given-names>Jinseo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47457"><name><surname>Fan</surname><given-names>Qing R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9330-0963</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-90985"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2340-8899</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-113901"><name><surname>Nelson</surname><given-names>Mark T</given-names></name><role>Reviewing editor</role><aff><institution>University of Vermont</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hc2405@cumc.columbia.edu</email> (HC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>08</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e49253</elocation-id><history><date date-type="received"><day>12</day><month>06</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>08</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Morgenstern et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Morgenstern et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-49253-v1.pdf"/><abstract><p>Inhibiting high-voltage-activated calcium channels (HVACCs; Ca<sub>V</sub>1/Ca<sub>V</sub>2) is therapeutic for myriad cardiovascular and neurological diseases. For particular applications, genetically-encoded HVACC blockers may enable channel inhibition with greater tissue-specificity and versatility than is achievable with small molecules. Here, we engineered a genetically-encoded HVACC inhibitor by first isolating an immunized llama nanobody (nb.F3) that binds auxiliary HVACC Ca<sub>V</sub>β subunits. Nb.F3 by itself is functionally inert, providing a convenient vehicle to target active moieties to Ca<sub>V</sub>β-associated channels. Nb.F3 fused to the catalytic HECT domain of Nedd4L (Ca<sub>V</sub>-aβlator), an E3 ubiquitin ligase, ablated currents from diverse HVACCs reconstituted in HEK293 cells, and from endogenous Ca<sub>V</sub>1/Ca<sub>V</sub>2 channels in mammalian cardiomyocytes, dorsal root ganglion neurons, and pancreatic β cells. In cardiomyocytes, Ca<sub>V</sub>-aβlator redistributed Ca<sub>V</sub>1.2 channels from dyads to Rab-7-positive late endosomes. This work introduces Ca<sub>V</sub>-aβlator as a potent genetically-encoded HVACC inhibitor, and describes a general approach that can be broadly adapted to generate versatile modulators for macro-molecular membrane protein complexes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 HL142111</award-id><principal-award-recipient><name><surname>Colecraft</surname><given-names>Henry M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 GM107585</award-id><principal-award-recipient><name><surname>Colecraft</surname><given-names>Henry M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F31 DK118866</award-id><principal-award-recipient><name><surname>Morgenstern</surname><given-names>Travis</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>S10RR027050</award-id><principal-award-recipient><name><surname>Morgenstern</surname><given-names>Travis</given-names></name><name><surname>Park</surname><given-names>Jinseo</given-names></name><name><surname>Fan</surname><given-names>Qing R</given-names></name><name><surname>Colecraft</surname><given-names>Henry M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30 CA013696</award-id><principal-award-recipient><name><surname>Morgenstern</surname><given-names>Travis</given-names></name><name><surname>Park</surname><given-names>Jinseo</given-names></name><name><surname>Fan</surname><given-names>Qing R</given-names></name><name><surname>Colecraft</surname><given-names>Henry M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#A3007-01) of Columbia University. Primary cultures of adult guinea pig heart ventricular cells were prepared in accordance with the guidelines of Columbia University Animal Care and Use Committee protocols (AC-AAAS5410). All surgery was performed under isoflurane anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-49253-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>